Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Centessa Pharmaceuticals Plc ADR (CNTA)

Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Centessa Pharmaceuticals Plc ADR 3rd Floor 1 Ashley Road Altrincham Cheshire X0 WA14 2DT GBR

www.centessa.com Employees: 77 P: 617-468-5770

Sector:

Medical

Description:

Centessa Pharmaceuticals plc is a clinical-stage company employing its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines to patients. Centessa Pharmaceuticals plc is based in Cambridge, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 2,984,147
Enterprise Value, $K 2,709,867
Shares Outstanding, K 134,421
Float, K 124,891
% Float 92.91%
Short Interest, K 6,248
Short Float 4.65%
Days to Cover 7.24
Short Volume Ratio 0.69
% of Insider Shareholders 7.09%
% of Institutional Shareholders 82.01%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -235,760 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,340 K
EBIT, $ -206,420 K
EBITDA, $ -205,480 K

Growth:

1-Year Return 51.19%
3-Year Return 466.33%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 11/05/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -1.29
EPS Growth vs. Prev Qtr -7.89%
EPS Growth vs. Prev Year -10.81%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CNTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.39%
Return-on-Assets % -34.64%
Profit Margin % 0.00%
Debt/Equity 0.32
Price/Sales 197.23
Price/Cash Flow N/A
Price/Book 9.86
Book Value/Share 2.58
Interest Coverage -22.08
60-Month Beta 1.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar